Berry meals and risk factors associated with metabolic syndrome

European Journal of Clinical Nutrition

Volumn 64, Issue 6, 2010, Pages 614-621

  Lehtonen, H M ^a   Suomela, J P ^a   Tahvonen, R ^b   Vaarno, J ^a   Venojarvi M ^c   Viikari, J ^d   Kallio, H ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b FINNISH FOREST RESEARCH INSTITUTE   (Finland)

^c TURKU UNIVERSITY OF APPLIED SCIENCES   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Adiponectin; ALAT; Metabolic syndrome; NAFLD; Northern berries

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BERRY; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DIETARY INTAKE; FEMALE; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NUTRITIONAL ASSESSMENT; OBESITY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADIPONECTIN; ADULT; ALANINE TRANSAMINASE; ANGIOSPERMS; FEMALE; FRUIT; HUMANS; LIFE STYLE; METABOLIC SYNDROME X; MIDDLE AGED; OVERWEIGHT; PLANT PREPARATIONS; RISK FACTORS;

EID: 77953233196     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2010.27     Document Type: Article

References (40)

1. Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J et al. (2006). Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49, 755-765.
2. Adiels M, Westerbacka J, Soro-Paavonen A, Häkkinen AM, Vehkavaara S, Caslake MJ et al. (2007). Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia 50, 2356-2365.
3. Angulo P (2002). Nonalcoholic fatty liver disease. N Engl J Med 346, 1221-1231.
4. Bao L, Yao X, Yau C, Tsi D, Chia CS, Nagai H et al. (2008). Protective effects of bilberry (Vaccinium myrtillus L.) extract on restraint stress-induced liver damage in mice. J Agric Food Chem 56, 7803-7807.
5. Bere E (2007). Wild berries: a good source of omega-3. Eur J Clin Nutr 61, 431-433.
6. Bugianesi E, McCullough A, Marchesini G (2005). Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 42, 987-1000.
7. World Medical Association Declaration of Helsinki (2000). Ethical Principles for Medical Research Involving Human Subjects. Viewed at http://www.wma.net/en/30publications/10policies/b3/ index.html, 31.3.2009.
8. Ekstedt M, Franzén L, Mathiesen U, Thorelius L, Holmqvist M, Bodemar G et al. (2006). Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44, 865-873.
9. Erlund I, Koli G, Alfthan J, Marniemi J, Puukka P, Mustonen P et al. (2008). Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr 87, 323-331.
10. Erlund I, Marniemi J, Hakala P, Alfthan G, Meririnne E, Aro A (2003). Consumption of black currants, lingonberries and bilberries increases serum quercetin concentrations. Eur J Clin Nutr 57, 37-43.
11. Greco D, Kotronen A, Westerbacka J, Puig O, Arkkila P, Kiviluoto T et al. (2008). Gene expression in human NAFLD. Am J Physiol 294, G1281-G1287.
12. Greenfield V, Cheung O, Sanyal AJ (2008). Recent advances in nonalcoholic fatty liver disease. Curr Opin Gastroenterol 24, 320-327. (Pubitemid 351535891)
13. Hanley A, Williams K, Festa A, Wagenknecht LE, D'Agostino Jr RB, Kempf J et al. (2004). Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 53, 2623-2632.
14. Jepson RG, Craig JC (2008). Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 1, CD001321.
15. Johansson A, Korte H, Yang B, Stanley JC, Kallio HP (2008). Sea buckthorn berry oil inhibits platelet aggregation. J Nutr Biochem 11, 491-495.
16. Juutilainen P, Seppälä K, Lampinen H (2000). Evaluation of the Konelab 20i Clinical Chemistry Analyzer. Laboratory Medicine 2000, XXVII Nordic Congress of Clinical Chemistry, Bergen, Norway, 4-8 June 2000.
17. Kallio H, Yang B, Peippo P (2002). Effects of different origins and harvesting time on vitamin C, tocopherols, and tocotrienols in sea buckthorn (Hippophae rhamnoides) berries. J Agric Food Chem 50, 6136-6142. (Pubitemid 35155347)
18. Kalt W, Forney CF, Martin A, Prior RL (1999). Antioxidant capacity, vitamin C, phenolics, and anthocyanins after fresh storage of small fruits. J Agric Food Chem 47, 4638-4644.
19. Kotronen A, Westerbacka J, Bergholm R, Pietiläinen K, Yki-Järvinen H (2007). Liver fat in the metabolic syndrome. J Clin Endocr Metab 92, 3490-3497.
20. Kotronen A, Yki-Järvinen H (2008). Fatty liver: a novel component of the metabolic syndrome. Arteroscler Thromb Vasc Biol 28, 2276-2283.
21. Laatikainen T, Tapanainen H, Alfthan G, Salminen I, Sundvall J, Leiviskä J et al. (2007). Tutkimuksen toteutus ja tulokset I. Publications of the National Public Health Institute, B7.
22. Lakka H, Lakka T, Tuomilehto J, Salonen JT (2002). Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J 23, 706-713.
23. Larmo P, Alin J, Salminen E, Kallio H, Tahvonen R (2008). Effects of sea buckthorn berries on infections and inflammation: a doubleblind, randomized, placebo-controlled trial. Eur J Clin Nutr 62, 1123-1130.
24. Määttä-Riihinen K, Kamal-Eldin A, Mattila P, González-Paramás AM, Törrönen AR (2004). Distribution and contents of phenolic compounds in eighteen Scandinavian berry species. J Agric Food Chem 52, 4477-4486.
25. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M et al. (2001). Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50, 1844-1850.
26. Marniemi J, Hakala P, Mäki J, Ahotupa M (2000). Partial resistance of low density lipoprotein to oxidation in vivo after increased intake of berries. Nutr Metab Cardiovasc Dis 10, 331-337.
27. Mokdad A, Ford E, Bowman B, Dietz WH, Vinicor F, Bales VS et al. (2001). Prevalence of obesity, diabetes, and obesity-related health risk factors. JAMA 289, 76-79.
28. Nakanishi N, Noriyuki MD, Suzuki K, Tatara K (2004). Serum gammaglutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 27, 1427-1432. (Pubitemid 38679993)
29. Ohlson O, Larsson B, Björntorp P, Eriksson H, Svärdsudd K, Welin L et al. (1988). Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia 31, 798-805.
30. Overbergh L, Decallonne B, Valcox D, Verstuyf A, Depovere J, Laureys J et al. (2000). Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol 120, 139-146.
31. Pittas A, Harris S, Stark B, Dawson-Hughes B (2007). The effects of calcium and vitamin D supplementation on blood glucose and markers and inflammation in nondiabetic adults. Diabetes Care 30, 980-986.
32. Ryysy L, Häkkinen AM, Goto T, Vehkavaara S, Westerbacka J, Halavaara J et al. (2000). Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49, 749-758.
33. Sattar N, Scherbakova O, Ford I, O'Reilly DS, Stanley A, Forrest E et al. (2004). Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland Coronary Prevention Study. Diabetes 53, 2855-2860.
34. Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi A et al. (2002). Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocr Metab 87, 3023-3028.
35. Tahvonen R, Schwab U, Linderborg K, Mykkänen HM, Kallio HP et al. (2005). Black currant seed oil and fish oil supplements differ in their effects on fatty acid profiles of plasma lipids, and concentrations of serum total and lipoprotein lipids, plasma glucose and insulin. J Nutr Biochem 16, 353-359.
36. Targher G, Berolini L, Padovani R, Rodella S, Tessari R, Zenari L et al. (2007). Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30, 1212-1218. (Pubitemid 46684650)
37. Tiikkainen M, Bergholm R, Vehkavaara S (2003). Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes 52, 701-707.
38. Valtueña S, Pellegrini N, Franzini L, Bianchi MA, Ardigò D, Del Rio D et al. (2008). Food selection based on total antioxidant capacity can modify antioxidant intake, systemic inflammation, and liver function without altering markers of oxidative stress. Am J Clin Nutr 87, 1290-1297.
39. Venojärvi M, Aunola S, Puhke R, Marniemi J, Hämälä inen H, Halonen JP et al. (2008). Exercise training with dietary counselling increases mitochondrial chaperone expression in middle-aged subjects with impaired glucose tolerance. BMC Endocr Disord 8, 3-14.
40. Vozarova B, Stefan N, Lindsay R, Saremi A, Pratley RE, Bogardus C et al. (2002). High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51, 1889-1895. (Pubitemid 34564303)